Page last updated: 2024-09-03

dx 9065a and Thromboembolism

dx 9065a has been researched along with Thromboembolism in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kaiser, B	1
Haas, S; Kubitza, D	1

Reviews

2 review(s) available for dx 9065a and Thromboembolism

Article	Year
DX-9065a Daiichi. Current opinion in investigational drugs (London, England : 2000), 2003, Volume: 4, Issue:9 Topics: Angina Pectoris; Anticoagulants; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Factor Xa Inhibitors; Humans; Molecular Structure; Naphthalenes; Propionates; Randomized Controlled Trials as Topic; Structure-Activity Relationship; Thromboembolism	2003
Novel factor Xa inhibitors for prevention and treatment of thromboembolic diseases. Expert opinion on investigational drugs, 2006, Volume: 15, Issue:8 Topics: Administration, Oral; Animals; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Factor Xa; Factor Xa Inhibitors; Fondaparinux; Humans; Injections, Intravenous; Injections, Subcutaneous; Morpholines; Naphthalenes; Oligosaccharides; Polysaccharides; Propionates; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Thromboembolism	2006

Article

Year

DX-9065a Daiichi.

Current opinion in investigational drugs (London, England : 2000), 2003, Volume: 4, Issue:9

Topics: Angina Pectoris; Anticoagulants; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Factor Xa Inhibitors; Humans; Molecular Structure; Naphthalenes; Propionates; Randomized Controlled Trials as Topic; Structure-Activity Relationship; Thromboembolism

2003

Novel factor Xa inhibitors for prevention and treatment of thromboembolic diseases.

Expert opinion on investigational drugs, 2006, Volume: 15, Issue:8

Topics: Administration, Oral; Animals; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Factor Xa; Factor Xa Inhibitors; Fondaparinux; Humans; Injections, Intravenous; Injections, Subcutaneous; Morpholines; Naphthalenes; Oligosaccharides; Polysaccharides; Propionates; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Thromboembolism

2006